Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.
Hinds
Pamela S
PS
Hockenberry
Marilyn
M
Feusner
James
J
Hord
Jeffrey D
JD
Rackoff
Wayne
W
Rozzouk
Bassem I
BI
D000293:Adolescent; D000740:Anemia / Q000097:blood* / Q000139:chemically induced / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D006397:Hematinics / Q000008:administration & dosage; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007165:Immunosuppression Therapy; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy; D010919:Placebos; D011788:Quality of Life; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D006397:Hematinics; D006454:Hemoglobins; D010919:Placebos; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa